RxDoctor Payments Data

Werner Wolff

Psychiatric/Mental Health · Fort Wayne, INNPI 1598395238

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.7% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $857 and has fallen 70.5% since, to $252 in 2025.

$2,346in general payments, 2019–2025

Across 136 payments — averaging $17.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$497
  • Lundbeck LLC$260
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$206
  • Johnson & Johnson$194
  • AbbVie$194
  • Otsuka America Pharmaceutical, Inc.$184
  • plus $812 from 12 others

What the payments were for

  • Food & beverage$2,24696%
  • Education$1004%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,346 in reported general payments places this provider in the 75th percentile of 729 psychiatric/mental health providers in Indiana.

See all psychiatric/mental health providers in Indiana →

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl39$57,785
Invega SustennaPaliperidone Palmitate12$43,838
Lurasidone Hcl16$11,014
Divalproex Sodium ErDivalproex Sodium22$3,912
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl22$3,264
Dexmethylphenidate Hcl ErDexmethylphenidate Hcl30$2,921
Clomipramine Hcl12$2,000
Clozapine15$1,614
Desvenlafaxine Succinate ErDesvenlafaxine Succinate38$1,595
Aripiprazole21$1,242
Buspirone Hcl58$1,162
Sertraline Hcl75$845
Mirtazapine40$721
Prazosin Hcl49$710
Duloxetine Hcl38$612

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$194$57,78539 claims
Johnson & JohnsonInvega Sustenna$194$43,83812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 729 psychiatric/mental health providers in Indiana.

Other psychiatric/mental health in Fort Wayne

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →